Neurogene (NasdaqGM:NGNE) Conference Transcript

Neurogene (NasdaqGM:NGNE) Conference October 14, 2025 07:00 AM ET Speaker0Hello everyone, my name is Mitchell Kapoor, I'm a Senior Biotech Analyst at H.C. Wainwright. It's my pleasure to welcome you to the Genetic Medicines Conference. Today we have the pleasure of having Neurogene Inc. and from the company I have Rachel McMinn, the CEO. Rachel, thank you so much for joining us today.Speaker1Yeah, thanks Mitchell for the opportunity. Looking forward to it.Speaker0Absolutely. A lot of recent news in the spac ...